Episode Details
Back to EpisodesWhat is the benefit of asprin in reducing colorectal cancer recurrence? Elizabeth Tracey reports
Published 2 months, 4 weeks ago
Description
People who’ve had colorectal cancer and who have a mutation known as PI3 kinase benefit from taking asprin to prevent recurrence, a new study shows. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, describes the findings. Nelson: There were …